" /> DC-MelVac - CISMeF





Preferred Label : DC-MelVac;

MeSH note : a second generation melanoma vaccine (DC-Melvac) that consists of five human melanoma cell lines, a recombinant vaccinia virus that encodes for IL-2, as well as dendritic cells that have been programmed to recognize certain melanoma associated antigens; approved by FDA in Phase I clinical trials 2/2008;

Is substance : O;

Details


You can consult :


Nous contacter.
08/06/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.